Notably, CXCL4 was found to play an important role in lung inflammation and tissue damage (57), and has been identified as a biomarker for early rheumatoid arthritis where it was co-localized with inflammatory cells and platelets in synovial tissue (23). Here, PF4 is linked to rheumatoid arthritis.